Lessing, C., Ashton, T., & Davis, P. (2015). An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality. Value in Health, 18(5), 646. https://doi.org/10.1016/j.jval.2015.02.020
Chicago Style (17th ed.) CitationLessing, Charon, Toni Ashton, and Peter Davis. "An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand Under Conditions of Price Neutrality." Value in Health 18, no. 5 (2015): 646. https://doi.org/10.1016/j.jval.2015.02.020.
MLA (9th ed.) CitationLessing, Charon, et al. "An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand Under Conditions of Price Neutrality." Value in Health, vol. 18, no. 5, 2015, p. 646, https://doi.org/10.1016/j.jval.2015.02.020.